Pluristem Therapeutics Inc (PSTI)

[FDApproved]

The Large Amounts Of PLX-R18 Human Data In Multiple Organs From Both Entities, IMO... Will Support FDA Fast-Track Approval !
Followed By The EMA And Japan.





http://www.genengnews.com/gen-news-highlights/pluristem-nybc-win-900k-to-test-plx-r18-cells-alongside-cord-blood-transplants/81253611



http://www.chemdiv.com/pluristem-fukushima-medical-university-evaluate-plx-r18-cells-radiation-treatment/


The parties will evaluate PLX-R18 cells as a potential treatment for radiation-induced damage to lungs, skin and gastrointestinal tract.

The research also includes development of preclinical prototypes of radiation damage in these tissues for use in clinical trials.

As part of the research, Pluristem will offer PLX-R18 cells and scientific know-how. Fukushima Medical University will carry out studies and supply the required resources.

The partnership will be conducted concurrently with a research being funded by the US National Institutes of Health (NIH), which is examining PLX-R18 cells as a potential treatment for hematologic component of ARS.